A vs ARTV · P/E 29, rev $1.88B vs $37.3M cap
Agilent Technologies Inc (A) versus Artiva Biotherapeutics, Inc. Common Stock (ARTV) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
A currently screens at market cap $33.70B and trailing P/E 29.2. ARTV currently screens at market cap $37.3M.
Not investment advice. Open the A and ARTV stock pages for the full models.
Not investment advice.